137 related articles for article (PubMed ID: 15167216)
41. Polymorphism and overexpression of HER2/neu among ovarian carcinoma women from Tiruchirapalli, Tamil Nadu, India.
Shanmughapriya S; Senthilkumar G; Arun S; Vinodhini K; Sudhakar S; Natarajaseenivasan K
Arch Gynecol Obstet; 2013 Dec; 288(6):1385-90. PubMed ID: 23722284
[TBL] [Abstract][Full Text] [Related]
42. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in a Chinese population.
Luo T; Chen L; He P; Hu QC; Zhong XR; Sun Y; Yang YF; Tian TL; Zheng H
Asian Pac J Cancer Prev; 2013; 14(4):2433-7. PubMed ID: 23725153
[TBL] [Abstract][Full Text] [Related]
43. Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.
Pooja S; Chaudhary P; Nayak LV; Rajender S; Saini KS; Deol D; Kumar S; Bid HK; Konwar R
Cytokine; 2012 Oct; 60(1):122-8. PubMed ID: 22818022
[TBL] [Abstract][Full Text] [Related]
44. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease.
Araújo AP; Ribeiro R; Pinto D; Pereira D; Sousa B; Mauricio J; Lopes C; Medeiros R
DNA Cell Biol; 2009 May; 28(5):265-9. PubMed ID: 19388850
[TBL] [Abstract][Full Text] [Related]
45. Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women.
Romanowicz-Makowska H; Smolarz B; Makowski M; Połać I; Pertyński T
Pol J Pathol; 2008; 59(4):201-4. PubMed ID: 19391486
[TBL] [Abstract][Full Text] [Related]
46. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
[TBL] [Abstract][Full Text] [Related]
47. ERBB2 genetic polymorphism and breast cancer risk in Chinese women: a population-based case-control study.
Qu S; Cai Q; Gao YT; Lu W; Cai H; Su Y; Wang SE; Shu XO; Zheng W
Breast Cancer Res Treat; 2008 Jul; 110(1):169-76. PubMed ID: 17687647
[TBL] [Abstract][Full Text] [Related]
48. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
[TBL] [Abstract][Full Text] [Related]
49. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
50. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.
Basham VM; Pharoah PD; Healey CS; Luben RN; Day NE; Easton DF; Ponder BA; Dunning AM
Carcinogenesis; 2001 Nov; 22(11):1797-800. PubMed ID: 11698341
[TBL] [Abstract][Full Text] [Related]
51. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
52. Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.
Wang H; Liu L; Lang Z; Guo S; Gong H; Guan H; Zhang J; Liu B
J Surg Oncol; 2013 Nov; 108(6):337-41. PubMed ID: 23900832
[TBL] [Abstract][Full Text] [Related]
53. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Naidu R; Har YC; Taib NA
J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
[TBL] [Abstract][Full Text] [Related]
54. Correlations of
Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
[TBL] [Abstract][Full Text] [Related]
55. Her2 genotype and breast cancer progression in Korean women.
An HJ; Kim NK; Oh D; Kim SH; Park MJ; Jung MY; Kang H; Kim SG; Lee KP; Lee KS
Pathol Int; 2005 Feb; 55(2):48-52. PubMed ID: 15693849
[TBL] [Abstract][Full Text] [Related]
56. The Association of
Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT
In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550
[TBL] [Abstract][Full Text] [Related]
57. 1236 C/T and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast cancer patients.
Gutierrez-Rubio SA; Quintero-Ramos A; Durán-Cárdenas A; Franco-Topete RA; Castro-Cervantes JM; Oceguera-Villanueva A; Jiménez-Pérez LM; Balderas-Peña LM; Morgan-Villela G; Del-Toro-Arreola A; Daneri-Navarro A
Genet Mol Res; 2015 Feb; 14(1):1250-9. PubMed ID: 25730063
[TBL] [Abstract][Full Text] [Related]
58. Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
Hashemi M; Sanaei S; Hashemi SM; Eskandari E; Bahari G
Clin Breast Cancer; 2018 Oct; 18(5):e883-e891. PubMed ID: 29439926
[TBL] [Abstract][Full Text] [Related]
59. Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population.
Parvin S; Islam MS; Al-Mamun MM; Islam MS; Ahmed MU; Kabir ER; Hasnat A
Breast Cancer; 2017 Mar; 24(2):229-237. PubMed ID: 27068824
[TBL] [Abstract][Full Text] [Related]
60. HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.
AbdRaboh NR; Shehata HH; Ahmed MB; Bayoumi FA
Dis Markers; 2013; 34(6):407-17. PubMed ID: 23594562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
